Bats Global Markets Inc

Bats Global Markets — Q3 2016 Earnings Presentation

45 slides from Bats Global Markets's earnings presentation, Oct 28, 2016

  1. Slide 1: Forward-Looking Statements

    Forward-Looking Statements This presentation contains certain statements regarding intentions, beliefs and expectations or predictions for the future of CBOE Holdings, Inc. (“CBOE”) and Bats Global Markets, Inc. (“Bats”), which are forward-looking statements as that term is defined in the Private Se

  2. Slide 2: Additional Information

    Additional Information Additional Information Regarding the Transaction and Where to Find It This presentation does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. This presentation is being made in respect of the propo

  3. Slide 3: Agenda

    Agenda Strategic Review Edward Tilly Chief Executive Officer Financial Review Alan Dean Executive Vice President, CFO and Treasurer Questions and Answers Edward Tilly Alan Dean Edward Provost President and Chief Operating Officer John Deters Chief Strategy Officer and Head of Corporate Initiatives

  4. Slide 4: Strategic Review

    Strategic Review Edward Tilly CEO

  5. Slide 5: Solid Third-Quarter Results; Difficult Comparison to 3Q15 Record High

    Trading in our proprietary index suite up 5% YTD¹ 3Q16 adjusted EPS of $0.58 on revenue of $156 million ADV for CBOE’s index suite up 5% YTD¹, led by 14% increase in VIX futures ADV for multiply-listed options traded industrywide down 4% YTD¹ Solid Third-Quarter Results; Difficult Comparison to 3Q15

  6. Slide 6: Key Events in Roadmap to Completion

    Key Events in Roadmap to Completion File registration statement and joint proxy statement with SEC CBOE and Bats shareholder votes Regulatory clearances, approvals and notifications Transaction expected to close during first half of 2017 Expand and diversify CBOE’s product line across new asset clas

  7. Slide 7: Product Development Remains Key to our Value Proposition

    Product Development Remains Key to our Value Proposition Product innovation is central to our value proposition and enables CBOE to offer the world’s widest array of options and volatility products Launched CBOE S&P 500 Smile Index in October A premium-capture strategy benchmark index Constructed to

  8. Slide 8: Expanding Options and Volatility Trading

    CBOE Vest Financial launched two new mutual funds CBOE Vest S&P 500 Buffer Protect Strategy Fund First mutual fund designed to provide investors with index-based buffer protection Designed to provide a risk-managed investment that seeks to protect against some downside losses in the S&P 500 index, w

  9. Slide 9: Leveraging Partnerships With Index Providers to Grow Index Product Line

    Expanding global customer base through joint trading and educational services with our index provider partners In 2015, launched options on MSCI EAFE Index and MSCI Emerging Markets Index Following concentrated business development efforts, begun to see growing traction in MSCI trading Plan to broad

  10. Slide 10: Expanding Our Global Customer Base

    Fifth annual CBOE Risk Management Conference (RMC) Europe took place Sept. 26 through 28 in Ireland Second RMC Asia to take place in Hong Kong Begins on November 30th 33rd annual CBOE RMC U.S. planned to take place in California on March 8-10, 2017 Expanding Our Global Customer Base Initiatives focu

  11. Slide 11: Forming Alliances that Leverage Our Strengths

    Teamed with London Stock Exchange Group (LSEG) and major dealer banks to form CurveGlobal, a new interest rate derivatives platform Launched on September 26th Products trade on the LSE Derivatives Market and clear through LCH.Clearnet Expected to provide more product choices, increased trading effic

  12. Slide 12: CBOE's Strategic Initiatives: Transaction Aligns with Strategy

    CBOE’s Strategic Initiatives Transaction Aligns with Strategy Develop unique products Strengthens CBOE’s global position in innovative, tradable products and services Expand our customer base Broadens geographic reach and enables company to build on relationships with market participants Form strate

  13. Slide 13: Financial Review

    Financial Review Alan Dean EVP, CFO and Treasurer

  14. Slide 14: 3Q16 Financial Overview

    3Q16 Financial Overview (in millions, except EPS and RPC) 3Q16 3Q15 $ Change % Change Operating Revenue $156.2 $187.0 $30.8 -16% Adjusted Operating Expenses¹ 81.4 85.9 -4.5 -5% Adjusted Operating Income¹ $74.8 $101.1 -$26.3 -26% Adjusted Operating Margin %¹ 47.9% 54.1% -620 bps Adjusted Net Income A

  15. Slide 15: Operating Revenue

    Operating Revenue Transaction fees down $32.9MM 12% decrease in RPC Shift in product mix Higher volume-related discounts 12% decrease in trading volume Operating Revenue (in millions) 3Q16 3Q15 % Chg Transaction fees $111.9 $144.8 -23% Access fees 13.0 13.1 -- Exchange services and other fees 11.6 1

  16. Slide 16: RPC Variance Reflects Product Mix and Volume-related Discounts

    RPC Variance Primarily Reflects Shift in Product Mix and Higher Volume-related Discounts Trading volume mix and RPC 3Q15 versus 3Q16 Equity 31.9% ETPs 27.4% Index 35.4% Futures 5.3% 3Q16 $1.709 $0.304 $0.707 $0.079 $0.050 3Q16 RPC $0.378 Equity 28.1% ETPs 27.3% Index 39.6% Futures 5.0% 3Q15

  17. Slide 17: Proprietary Products Account for Growing Percentage of Transaction Fee Revenue

    Proprietary Products Account for Growing Percentage of Transaction Fee Revenue Index options and futures contracts accounted for 90.0% of transaction fees in 3Q16 versus 84.0% in 3Q15 and 87.9% in 2Q16 19.0% 18.3% 18.4% 23.6% 23.8% 65.0% 64.8% 67.4% 64.3% 66.2% 9.0% 8.9% 7.8% 6.9% 5.8% 7.0% 8.0% 6.4

  18. Slide 18: Other Factors Influencing Operating Revenue

    Other Factors Influencing Operating Revenue Market data fees up $1.1MM Higher revenue from OPRA market data and proprietary index data Regulatory fees up $0.9MM Exchange services and other fees up $0.6MM Primarily reflects revenue from CBOE Livevol Other revenue down $0.4MM Mainly due to lower reven

  19. Slide 19: Ongoing Focus on Prudent Expense Management

    Largest expense variances aligned with performance and volume: Adjusted Operating Expenses¹ (in millions) 3Q16 3Q15 % Chg Compensation and benefits¹ $28.1 $29.6 -5% Depreciation and amortization¹ 9.9 12.4 -20% Technology support services 5.6 5.3 6% Professional fees and outside services¹ 12.8 12.6 2

  20. Slide 20: Core Operating Expenses

    Key drivers: Core Operating Expenses¹ (in millions) 3Q16 3Q15 % Chg Compensation and benefits¹ $28.1 $29.6 -5% Technology support Services 5.6 5.3 6% Professional fees and outside services¹ 12.8 12.6 2% Travel and promotional 2.6 1.4 86% Facilities costs 1.3 0.9 44% Other expenses 1.2 1.3 -8% Total

  21. Slide 21: 2016 Full-Year Guidance

    2016 Full-Year Guidance As of October 28, 2016 ($ in millions) Full-Year Guidance as of July 29, 2016 Updated Guidance as of October 28, 2016 Core operating expenses $211 to $215 Expect to be slightly below range of $211 to $215 Continuing stock-based compensation¹ $13.5 $13.5 Accelerated stock-base

  22. Slide 22: Volume-based Expenses

    Volume-based Expenses Royalty fees down $2.4MM Lower trading volume in licensed products in 3Q16 versus 3Q15 Index complex volume down 19% Shift in mix of licensed products traded resulted in higher royalty fee per licensed contract Volume-based Expenses (in millions) 3Q16 3Q15 % Chg Royalty fees $1

  23. Slide 23: Enhancing Shareholder Value

    Enhancing Shareholder Value ’11 - ’15 CAGR 5% Strong cash flow generation and disciplined approach to managing cash Cash of $73 million at Sept. 30, 2016 Generated $174 million in operating cash flow YTD¹ Capital outlays YTD¹: $36 million for capital expenditures $58 million to pay dividends $65 mil

  24. Slide 24: Committed to Returning Capital to Shareholders

    Expect to maintain a strong balance sheet and flexibility for: Capital expenditures Dividend payments Opportunistic share repurchases Other strategic initiatives Committed to Returning Capital to Shareholders ¹YTD through September 30, 2016 $47 $50 $45 $168 $132 $60 2011 2012 2013 2014 2015 2016 TD¹

  25. Slide 25: Committed to Returning Capital to Shareholders

    [esr HOLDINGS Committed to Returning Capital to Shareholders > Expect to maintain a strong balance sheet and flexibility for: e Capital expenditures e Dividend payments e Opportunistic share repurchases e Other strategic initiatives Change in Quarterly Dividend Rate Per Share at 0.25 iq -16. CAG Snr

  26. Slide 26: Appendix Materials

    Appendix Materials

  27. Slide 27: Solid YTD Results Reflect Commitment to Strategic Initiatives

    Solid YTD Results Reflect Companywide Commitment to Executing our Strategic Initiatives ¹YTD through September 30, 2016 ²Adjusted to reflect the impact of certain items. See appendix for “Non-GAAP Information.” $508 $512 $572 $617 $633 $479 $482 2011 2012 2013 2014 2015 2015 TD¹ 2016 TD¹ Adjusted Op

  28. Slide 28: Optimistic About Long-Term Growth Prospects

    ¹Adjusted to reflect the impact of certain items. See Appendix for “Non-GAAP Information.” Optimistic About Long-Term Growth Prospects $0.20 $0.25 $0.30 $0.35 $0.40 $0.45 $0.50 $0.55 $0.60 $0.65 $0.70 $0.75 $0.80 $0 $20 $40 $60 $80 $100 $120 $140 $160 $180 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q1

  29. Slide 29: 2016 Financial Overview

    2016 Financial Overview (in millions, except EPS and RPC) 9 mos. Ended 09/30/16 9 mos. Ended 09/30/15 $ Change % Change Operating Revenue $481.9 $478.6 $3.3 1% Adjusted Operating Expenses¹ 247.0 234.6 12.4 5% Adjusted Operating Income¹ $234.9 $244.0 -$9.1 -4% Adjusted Operating Margin %¹ 48.7% 51.0%

  30. Slide 30: Proprietary Products Account for Growing Percentage of Transaction Fee Revenue

    Proprietary Products Account for Growing Percentage of Transaction Fee Revenue Index options and futures contracts account for 87.9% of transaction fees through Sept. ‘16, up from 50.6% in 2010 ¹YTD Through September 30, 2016 2.3% 4.6% 10.5% 15.9% 18.8% 19.2% 21.9% 48.3% 52.9% 57.2% 62.9% 63.0% 63.7

  31. Slide 31: RPC Variance Reflects Product Mix and Volume-related Discounts

    RPC Variance Primarily Reflects Shift in Product Mix and Higher Volume-related Discounts Trading Volume Mix & RPC 3Q15 vs 3Q16 Equity 31.9% ETPs 27.4% Futures 5.3% S&P Indexes 21.9% VIX 11.9% Other 1.6% Index 35.4% 3Q16 Trading Volume Mix $1.647 $0.368 $0.709 $0.143 $0.106 3Q15 RPC $0.431 $1.709 $0.

  32. Slide 32: CBOE and C2 Quarterly Options ADV

    CBOE and C2 Quarterly Options ADV (in millions) Quarterly Options ADV 1.60 1.60 1.77 1.91 2.17 1.81 1.85 1.94 1.81 1.53 1.48 1.43 1.45 1.36 1.48 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 Equity Options (in millions) 1.11 1.64 1.32 1.33 1.50 1.39 1.42 1.71 1.37 1.22 1

  33. Slide 33: Further Developing Current Products to Grow Index Product Line

    Further Developing Current Products to Grow Index Product Line S&P 500® Index (SPX) options, the most actively traded U.S. index option SPX ADV up 5% YoY through September Introduced SPX Weeklys with Wednesday Expirations on Feb. 23 Increases opportunities to trade SPX Wednesday expirations averaged

  34. Slide 34: Leveraging VIX Methodology to Create New Products

    Leveraging VIX® Methodology to Create New Products and Grow Index Product Line CBOE Volatility Index® (VIX Index) is considered the world’s barometer of equity market volatility VIX options ADV up 4% YoY through September VIX futures ADV up 14% YoY through September Launched VIX Weeklys futures in J

  35. Slide 35: Broadening Access to Proprietary Products

    Over 11% of VIX futures traded during non-U.S. hours through September 2016, up from 9% for full-year 2015 Broadening Access to Proprietary Products ¹Extended hours to nearly 24X5 on June 22, 2014 *Hours in Central Time Zone Generally, on days when volatility spikes, overnight volume increases and a

  36. Slide 36: CBOE Holdings Rolling 3-Month RPC

    CBOE Holdings Rolling 3-Month RPC 2016 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Equities $0.095 $0.092 $0.085 $0.081 $0.075 $0.070 $0.063 $0.057 $0.050 Exchange-traded products 0.138 0.131 0.117 0.111 0.104 0.103 0.096 0.089 0.079 Indexes 0.738 0.733 0.720 0.706 0.698 0.701 0.704 0.706 0.707

  37. Slide 37: Quarterly Core Operating Expenses

    Quarterly Core Operating Expenses¹ ($ in thousands) 3Q 2016 % rev 2Q 2016 % rev 1Q 2016 % rev 4Q 2015 % rev 3Q 2015 % rev 2Q 2015 % rev 1Q 2015 % rev 4Q 2014 % rev 3Q 2014 % rev 2Q 2014 % rev 1Q 2014 % rev 4Q 2013 % rev 3Q 2013 % rev 2Q 2013 % rev 1Q 2013 % rev 4Q 2012 % rev 3Q 2012 % rev 2Q 2012 %

  38. Slide 38: Annual Core Operating Expenses

    Annual Core Operating Expenses¹ ($ in thousands) 2016 YTD % rev 2015 % rev 2014 % rev 2013 % rev 2012 % rev 2011 % rev 2010 % rev 2009 % rev 2008 % rev Total Operating Expenses $258,768 54% $314,617 50% $303,424 49% $286,236 50% $268,241 52% $266,512 52% $269,763 62% $248,497 62% $229,473 55% Less:

  39. Slide 39: GAAP to Non-GAAP Reconciliation For 2010 and 2011

    May not foot due to rounding and/or change in shares outstanding GAAP to Non-GAAP Reconciliation For 2010 and 2011

  40. Slide 40: GAAP to Non-GAAP Reconciliation For 2012 and 2013

    GAAP to Non-GAAP Reconciliation For 2012 and 2013 GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) 1Q12 2Q12 3Q12 4Q12 FY2012 1Q13 2Q13 3Q13 4Q13 FY2013 Reconciliation of GAAP Net Income Allocated to Common Stockholder to Non-GAAP GAAP net income allocated to common stockhold

  41. Slide 41: GAAP to Non-GAAP Reconciliation For 2014 and 2015

    GAAP to Non-GAAP Reconciliation For 2014 and 2015 GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) 1Q14 2Q14 3Q14 4Q14 FY2014 1Q15 2Q15 3Q15 4Q15 FY2015 Reconciliation of GAAP Net Income Allocated to Common Stockholder to Non-GAAP GAAP net income allocated to common stockhold

  42. Slide 42: GAAP to Non-GAAP Reconciliation For 2016

    GAAP to Non-GAAP Reconciliation For 2016 5For the third quarter of 2015, the company recorded a benefit from the release of an uncertain tax position related to research and development credits, which were effectively settled. For the third quarter of 2016, the company no longer considers certain po

  43. Slide 43: Non-GAAP Information

    In addition to disclosing results determined in accordance with GAAP, CBOE Holdings has disclosed certain non-GAAP measures of operating performance. These measures are not in accordance with, or a substitute for, GAAP, and may be different from or inconsistent with non-GAAP financial measures used

  44. Slide 44: CBOE contact information

    CBOE 400 South LaSalle Street Chicago, Illinois 60605 www.cboe.com

  45. Slide 45: CBOE contact information

    CBOE 400 South LaSalle Street Chicago, Illinois 60605

Bats Global Markets — Q3 2016 Earnings Presentation on 6ix